| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 10.02.
| Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BIO CEO and Investor Conference | | 48 | Business Wire |
| Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its
presentation at the 14th Annual BIO CEO & Investor Conference will be
webcast and may be accessed at...
Mehr lesen zu:
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BIO CEO and Investor Conference | |
| 07.02.
| Critical Alerts For Halliburton, Travelers, Express Scripts, HCA, and Human Genome Sciences Released By Seven Summits Research | | 31 | PR Newswire |
| CHICAGO, Feb. 7, 2012 /PRNewswire/ --Seven Summits Research issues critical PriceWatch Alerts for HAL, TRV, ESRX, HCA, and HGSI.
To see what our analysts have discovered about these stocks read...
Mehr lesen zu:
Critical Alerts For Halliburton, Travelers, Express Scripts, HCA, and Human Genome Sciences Released By Seven Summits Research | |
| 07.02.
| Perception, Opportunity in Volatility - Research & Analysis on Human Genome Sciences and Merck & Co., Inc. | | 34 | MarketWire |
| HONG KONG -- (Marketwire) -- 02/07/12 -- This morning, www.MarketFoundations.com announced new reports highlighting Human Genome Sciences (NASDAQ: HGSI) and Merck & Co., Inc. (NYSE: MRK). Free research...
Mehr lesen zu:
Perception, Opportunity in Volatility - Research & Analysis on Human Genome Sciences and Merck & Co., Inc. | |
| 06.02.
| Zeldes & Haeggquist, LLP Announces Investigation of Human Genome Sciences, Inc. (HGSI) | | 32 | Business Wire |
| Zeldes & Haeggquist, LLP, a shareholder and consumer rights litigation
firm, has commenced an investigation into Human Genome Sciences, Inc.
(NASDAQ: HGSI) to determine...
Mehr lesen zu:
Zeldes & Haeggquist, LLP Announces Investigation of Human Genome Sciences, Inc. (HGSI) | |
| 01.02.
| Singapore Scientists Lead in 3D Mapping of Human Genome to Help Understand Human Diseases | | 51 | JCN Newswire |
| Singapore, Feb 1, 2012 - (ACN Newswire) - Genome Institute of Singapore's (GIS) Associate Director of Genomic Technologies, Dr Yijun RUAN, led a continuing study on the human genome spatial/structural...
Mehr lesen zu:
Singapore Scientists Lead in 3D Mapping of Human Genome to Help Understand Human Diseases | |
| 30.01.
| Uptrend Call Working As Human Genome Sciences Stock Rises 17.8% | | 20 | SmarTrend |
| 25.01.
| Shares of Human Genome Sciences Receive a Boost, Up 8.9% | | 26 | SmarTrend |
| 25.01.
| 2-Star Stocks Poised to Plunge: Human Genome? | | 21 | Motley Fool |
| 25.01.
| Boost in Biotech Funding Benefits CEL-SCI and Human Genome Sciences / The Paragon Report Provides Equity Research on CEL-SCI & Human Genome Sciences | | 58 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 01/25/12 -- The biotechnology industry has performed well in the early stages of 2012. The iShares NASDAQ Biotechnology Index is presently up nearly eight percent month-on-month...
Mehr lesen zu:
Boost in Biotech Funding Benefits CEL-SCI and Human Genome Sciences / The Paragon Report Provides Equity Research on CEL-SCI & Human Genome Sciences | |
| 24.01.
| Human Genome Sciences Set to Possibly Pullback After Yesterday's Rally of 2.36% | | 8 | SmarTrend |
| 22.01.
| deCODE Genetics, in Collaboration with Academic Colleagues, Discovers Three Variants in the Sequence of the Human Genome that Affect the Risk of Thyroid Cancer | | 73 | PR Newswire |
| REYKJAVIK, Iceland, January 22, 2012 /PRNewswire/ --
Scientists at deCODE Genetics and academic collaborators from Iceland, the USA, The Netherlands and Spaintoday report the discovery of variants...
Mehr lesen zu:
deCODE Genetics, in Collaboration with Academic Colleagues, Discovers Three Variants in the Sequence of the Human Genome that Affect the Risk of Thyroid Cancer | |
| 19.01.
| Complete Genomics: Complete Genomics Publishes Paper Describing Its Informatics Approach for High-Accuracy Whole Human Genome Sequencing | | 13 | GlobeNewswire |
| MOUNTAIN VIEW, Calif., 2012-01-19 14:00 CET (GLOBE NEWSWIRE) --
Complete Genomics Inc. (Nasdaq:GNOM) announced today that the Journal of
Computational Biology has published online the company's paper...
Mehr lesen zu:
Complete Genomics: Complete Genomics Publishes Paper Describing Its Informatics Approach for High-Accuracy Whole Human Genome Sequencing | |
| 19.01.
| Complete Genomics Publishes Paper Describing Its Informatics Approach for High-Accuracy Whole Human Genome Sequencing | | 52 | dpa-AFX |
| Complete Genomics Publishes Paper Describing Its Informatics
Approach for High-Accuracy Whole Human Genome Sequencing
Complete Genomics
19.01.2012 14:00
--------------------------------------------------------------------
-------
MOUNTAIN...
Mehr lesen zu:
Complete Genomics Publishes Paper Describing Its Informatics Approach for High-Accuracy Whole Human Genome Sequencing | |
| 18.01.
| Buy, Sell, or Hold: Human Genome Sciences | | 32 | Motley Fool |
| 12.01.
| Possible Bearish Inside Day Candle Pattern Detected for Human Genome Sciences | | 13 | SmarTrend |
| 10.01.
| Life Technologies Introduces the Benchtop Ion Proton' Sequencer; Designed to Decode a Human Genome in One Day for $1,000 | | 123 | PR Newswire |
| SAN FRANCISCO, Jan. 10, 2012 /PRNewswire/ --Life Technologies Corporation (NASDAQ: LIFE) today announced it is taking orders for the new benchtop Ion Proton' Sequencer that is...
Mehr lesen zu:
Life Technologies Introduces the Benchtop Ion Proton' Sequencer; Designed to Decode a Human Genome in One Day for $1,000 | |
| 09.01.
| Stock Investors Bid Up Shares of Human Genome Sciences, Up 6.3% | | 12 | SmarTrend |
| 09.01.
| Human Genome Sciences and Oncothyreon -- Strong Growth Stories for 2012 / Five Star Equities Provides Stock Research on Human Genome Sciences & Oncothyreon | | 66 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 01/09/12 -- Biotechnology stocks have performed well in the early stages of the New Year. Last Thursday, the NYSE Arca Biotechnology Index skyrocketed as much as 3...
Mehr lesen zu:
Human Genome Sciences and Oncothyreon -- Strong Growth Stories for 2012 / Five Star Equities Provides Stock Research on Human Genome Sciences & Oncothyreon | |
| 09.01.
| Human Genome Announces Progress With Commercialization Of BENLYSTA | | 48 | AFX News |
| WASHINGTON (dpa-AFX) - Human Genome Sciences Inc. (HGSI) said it would
announce its priority goals for 2012 and report on progress with the
commercialization of BENLYSTA, the first approved...
Mehr lesen zu:
Human Genome Announces Progress With Commercialization Of BENLYSTA | |
| 09.01.
| Human Genome Sciences (HGSI) Announces 2012 Priority Goals and Updates Commercialization of BENLYSTA | | 3 | StreetInsider.com |
